Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.
Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collée MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gómez García E, Menko F, Oosterwijk JC, Devilee P, van't Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC; HEBON Resource. Brohet RM, et al. Among authors: hoogerbrugge n. J Med Genet. 2014 Feb;51(2):98-107. doi: 10.1136/jmedgenet-2013-101974. Epub 2013 Nov 27. J Med Genet. 2014. PMID: 24285858
Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. van Roosmalen MS, et al. Among authors: hoogerbrugge n. J Clin Oncol. 2004 Aug 15;22(16):3293-301. doi: 10.1200/JCO.2004.05.066. J Clin Oncol. 2004. PMID: 15310772 Free article. Clinical Trial.
Cost effectiveness of a new strategy to identify HNPCC patients.
Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HF, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Kievit W, et al. Among authors: hoogerbrugge n. Gut. 2005 Jan;54(1):97-102. doi: 10.1136/gut.2004.039123. Gut. 2005. PMID: 15591512 Free PMC article.
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, Leenders EP, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg MJ, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk JC. Leegte B, et al. Among authors: hoogerbrugge n. J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243. J Med Genet. 2005. PMID: 15744030 Free PMC article. Review. No abstract available.
The decision evaluation scales.
Stalmeier PF, Roosmalen MS, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Moog U, Hoogerbrugge N, van Daal WA. Stalmeier PF, et al. Among authors: hoogerbrugge n. Patient Educ Couns. 2005 Jun;57(3):286-93. doi: 10.1016/j.pec.2004.07.010. Patient Educ Couns. 2005. PMID: 15893210 Free article.
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP).
Nielsen M, Franken PF, Reinards TH, Weiss MM, Wagner A, van der Klift H, Kloosterman S, Houwing-Duistermaat JJ, Aalfs CM, Ausems MG, Bröcker-Vriends AH, Gomez Garcia EB, Hoogerbrugge N, Menko FH, Sijmons RH, Verhoef S, Kuipers EJ, Morreau H, Breuning MH, Tops CM, Wijnen JT, Vasen HF, Fodde R, Hes FJ. Nielsen M, et al. Among authors: hoogerbrugge n. J Med Genet. 2005 Sep;42(9):e54. doi: 10.1136/jmg.2005.033217. J Med Genet. 2005. PMID: 16140997 Free PMC article.
346 results